GARDASIL is the first HPV vaccine approved for the prevention of certain HPV-related cancers and diseases in Chinese males ...

Merck's Gardasil vaccine, previously only available to women, has now been approved for men in China. This approval may help ...

In the future people will be able to avoid daily radiation therapy, hospital stays, chemotherapy infusions, infections, and other tough parts of cancer treatment, the columnist writes.

The China National Medical Products Administration (NMPA) has granted expanded approval to MSD's GARDASIL, [Human ...

With a market cap of $252.6 billion, Rahway, New Jersey-based Merck & Co., Inc. (MRK) is a global leader in the healthcare ...

The HPV vaccine, Gardasil, has gained approval for additional indications from China's National Medical Products ...

Merck's human papillomavirus vaccine has been approved for men in China, it said on Wednesday, providing the U.S. drugmaker a ...

The recipient in Changsha, the capital of Hunan province, became the first man on the Chinese mainland to receive the HPV ...

U.S. drugmaker Merck & Co has received approval in China for its HPV vaccine's use in males, expanding its market reach despite earlier weak sales in the region. This move marks a potential growth ...

U.S. drugmaker Merck & Co on Wednesday announced that its human papillomavirus (HPV) vaccine for men has been approved by ...

China’s drug regulator approved Merck & Co.’s blockbuster HPV vaccine for use by men, opening a new untapped market for the ...

As a wave of volatility has been re-introduced to the system, investors are flocking toward blue-chip companies for stability ...